Representatives from the Chinese side say they think it likely that Chinese President Xi Jinping will attend the G-20 meeting later this month. But in order to reach a trade...China Economyread more
Software engineers straight out of college often make six-figure salaries, not counting equity compensation.Technologyread more
Wall Street, though, is clamoring for a rate cut, with an 85% chance of a move in July and a 61% probability of three reductions by year's end.The Fedread more
A company spokesperson said the outage was the result of a "an internal technology issue" and was not security related.Retailread more
The flattening of the yield curve is exuding a bad omen for the stock market if history is any guide.Marketsread more
Using MIT's living wage calculator, CNBC Make It mapped out the minimum amount a single parent must earn to meet their basic needs without relying on outside help in every...Earnread more
Hong Kong Chief Executive Carrie Lam announced at a press conference on Saturday that a contentious bill to allow extraditions to mainland China has been put on hold.China Politicsread more
Stratolaunch, the world's largest airplane, which flew once, is up for sale, sources familiar told CNBC.Investing in Spaceread more
Transparency is key… or is it? With the first-ever non-transparent, actively managed exchange-traded fund receiving approval from the SEC, "ETF Edge" goes straight to the...ETF Edgeread more
Mired in a crisis over its best-selling 737 Max plane, Boeing could hand the spotlight over to its rival Airbus at the Paris Air Show.Airlinesread more
A new update to the Apple Watch called watchOS 6 will notify you if the environment you're in is too loud and could damage your hearing.Technologyread more
(Updates with details of court ruling)
PARIS, Jan 15 (Reuters) - A French court cancelled the licence for one of Monsanto's glyphosate-based weedkillers on Tuesday over safety concerns, in the latest blow to the Bayer-owned business.
Germany's Bayer, which bought Monsanto for $63 billion last year, faces thousands of U.S. lawsuits by people who say its Roundup and Ranger Pro products caused their cancer.
A court in Lyon in southeast France ruled that the approval granted by French environment agency ANSES in 2017 for Roundup Pro 360 had failed to take into account potential health risks.
Bayer has cited regulatory rulings as well as scientific studies that found glyphosate to be safe and the firm is appealing a first U.S. court ruling that awarded $78 million in damages to a school groundskeeper from California.
Glyphosate, which is off-patent and marketed worldwide by dozens of other chemical groups including Syngenta and DowDuPont's Corteva Agriscience, is due to be phased out in France within three years under a pledge by President Emmanuel Macron, who stopped short of an outright ban.
The French court said ANSES had not respected a precautionary principle in French law, notably by not conducting a specific evaluation of health risks for Roundup Pro 360.
"Despite the European Union's approval of the active substance (glyphosate), the court considered that scientific studies and animal experiments showed Roundup Pro 360, a preparation whose toxicity is greater than that of glyphosate, is a potentially carcinogenic product for humans, suspected of being toxic for human reproduction and for aquatic organisms," the court said in a summary of its ruling.
Neither ANSES nor Bayer had immediate comment on the ruling.
"This is a great first, which must be repeated," Corinne Lepage, a former French environment minister and member of environment association CRIIGEN that brought the court case, said of the ruling on Twitter.
The association had also contested the process by which the EU renewed the general licence for glyphosate, seeking a referral to the European Court of Justice, but the French administrative court said such action was not necessary. (Reporting by Sudip Kar-Gupta and Gus Trompiz Editing by Ludwig Burger and Alexander Smith)